Medscape: Mild Liver Enzyme Increases Seen in COVID-19 Patients in China
July 4, 2020
UC digestive diseases expert Kenneth Sherman, MD, PhD, discusses study showing COVID-19 patients in China shown mildly elevated liver enzyme levels.
July 4, 2020
UC digestive diseases expert Kenneth Sherman, MD, PhD, discusses study showing COVID-19 patients in China shown mildly elevated liver enzyme levels.
August 26, 2020
Jennifer Forrester, MD, associate professor of infectious diseases in the UC College of Medicine and UC Health physician, told WLWT that she appreciates the attention flu vaccines are suddenly getting from area residents. “There is nothing particularly wrong or harmful in getting the flu vaccine now versus waiting,” Forrester told WLWT.
September 14, 2020
Carl Fichtenbaum, MD, was interviewed by CNN for a story they published about a delay in the Astra-Zeneca COVID-19 vaccine trial.
October 10, 2020
The Cincinnati Enquirer spoke with Dr. Shailendra Patel, a professor and director of the UC Division of Endocrinology, Diabetes and Metabolism and UC Health physician, about a US Food and Drug Administration recall of an anti-diabetes medication. He offered a message for patients who use metformin: do not quite the drug cold turkey.
November 4, 2020
A University of Cincinnati researcher is recommending pediatric hospital emergency room consider screening for sexually transmitted infections, teenage and young patients who visit for other acute care issues. Findings by Dr. Mark Eckman, professor and director of the UC Division of General Internal Medicine, appear in the Journal of American Medical Association Pediatrics.
April 14, 2022
A report published recently in JAMA Open Network finds there's a strong likelihood that the antidepressant fluvoxamine (Luvox) may moderately lower rates of hospitalization due to COVID-19 in unvaccinated patients. However, outside experts cited by Medscape differ over whether the evidence from just three studies is strong enough to warrant adding the drug to the COVID-19 armamentarium. One of those experts sources is Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
September 29, 2021
Several companies, including Pfizer are developing a pill to fight COVID-19 symptoms. Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed by WKRC-TV, Local12 for a story about the antiviral medications and explained how they work.
October 8, 2021
Carl Fichtenbaum, MD, and Jennifer Forrester, MD, both of the Division of Infectious Diseases at the UC College of Medicine were interviewed for a story posted on Cincinnati.com on what experts would advise parents to do in regards to handing out candy on Halloween.
October 11, 2021
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was one of the sources cited in an article in Medscape on pharmaceutical company Merck developing a new pill for COVID-19. Fichtenbaum said it wasn't a 'home run' but it was encouraging.